Medical and Interventional Treatment of Refractory Angina
نویسندگان
چکیده
Refractory Angina Pectoris is a chronic pain condition relating to myocardial ischaemia in the presence of coronary artery disease despite optimal medical therapy. It affects cohort patients with subset perfusion deficiencies. While there no cure for these patients, an array and interventional treatment available 2021. In this article we discuss options explanation mechanisms action evidence their use.
منابع مشابه
Interventional treatment of pain in refractory angina. A review.
BACKGROUND Refractory angina is characterized by repeated attacks of chest pain in patients on maximal anti-anginal pharmacotherapy, with a professional conscensus that further surgical or radiological revascularization would be futile. Refractory angina is a serious but relatively uncommon health problem, with a reported incidence of approximately 30 patients per million people/year. In this c...
متن کاملPrinzmetal’s angina refractory to medical treatment
We describe a case of Prinzmetal’s angina that is refractory to medical therapy but responded fully after percutaneous coronary intervention. This case shows that there is a role for percutaneous coronary intervention in refractory variant angina as long as a culprit lesion within the vasospastic segment can be identified.
متن کاملNonconventional therapeutic modalities in refractory angina pectoris
Abstract Despite sophisticated conventional medical treatment and the continued development and improvement of coronary revascularization modalities in recent years, a significant number of patients still suffer from refractory angina pectoris and cannot be successfully managed. Advances in therapeutic options have led to an increase in the average of life expectancy even in such ...
متن کاملEnhanced external counterpulsation as initial revascularization treatment for angina refractory to medical therapy.
Enhanced external counterpulsation (EECP) is effective in patients with angina refractory to medical therapy or revascularization. However, as a noninvasive treatment it should perhaps be considered the first-line treatment with invasive revascularization reserved for EECP failures or high-risk patients. The International EECP Patient Registry was used to analyze a cohort of patients with prior...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of cardiovascular disorders
سال: 2021
ISSN: ['2379-7991']
DOI: https://doi.org/10.26420/jcardiovascdisord.2021.1048